**Core Concept**
The question tests the student's knowledge of pharmacological principles related to anaesthesia and porphyria, a group of disorders that result from a buildup of porphyrins in the body. **Porphyrias** are caused by deficiencies in enzymes involved in the biosynthesis of **heme**. Certain anaesthetic agents can exacerbate porphyria by inducing the enzymes involved in the heme biosynthetic pathway.

**Why the Correct Answer is Right**
Although the specific correct answer is not provided, typically, **barbiturates** are known to be contraindicated in porphyria because they induce the cytochrome P450 system, which in turn increases the synthesis of **delta-aminolevulinic acid (ALA) synthase**, the rate-limiting step in heme synthesis. This can worsen the symptoms of porphyria.

**Why Each Wrong Option is Incorrect**
**Option A:** Without the specific options, it's challenging to provide detailed explanations, but generally, other anaesthetic agents like **propofol** are considered safe in porphyria.
**Option B:** Similarly, without specifics, it's hard to comment, but **etomidate** might be another agent that could be considered, though its use in porphyria is less clear-cut than barbiturates.
**Option C:** and **Option D:** would follow a similar pattern of explanation based on their pharmacological properties and effects on the heme biosynthesis pathway.

**Clinical Pearl / High-Yield Fact**
A key point to remember is that **barbiturates** are generally contraindicated in patients with **acute intermittent porphyria** due to their potential to precipitate acute attacks. Always consider the patient's porphyria status when selecting anaesthetic agents.

**Correct Answer:** D. Barbiturates